Edgewise Therapeutics EWTX
NASDAQ EWTX
$43.07 +1.12 (+2.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Edgewise Therapeutics (EWTX) Prepaid Assets (2020 - 2026)

Edgewise Therapeutics (EWTX) posted Prepaid Assets of $10.2 million for Q1 2026, down 22.94% sequentially from $13.3 million in Q4 2025, and up 50.64% YoY from $6.8 million in Q1 2025.

Analysis

Edgewise Therapeutics (EWTX) Prepaid Assets (2020 - 2026) Analysis & Trends

Edgewise Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $10.2 million in Q1 2026.

  • Quarterly Prepaid Assets rose 50.64% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (up 50.64% YoY) and the FY2025 annual result came in at $13.3 million, up 149.88% from the prior year.
  • Prepaid Assets declined to $10.2 million in Q1 2026 per EWTX's latest filing, from $13.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $13.3 million in Q4 2025 and troughed at $2.8 million in Q1 2022.
  • A 5-year average of $7.4 million and a median of $7.1 million in 2023 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 313.06% in 2022, then tumbled 38.25% in 2024.
  • Over 5 years, Prepaid Assets stood at $5.1 million in 2022, then soared by 70.31% to $8.6 million in 2023, then plunged by 38.25% to $5.3 million in 2024, then surged by 149.88% to $13.3 million in 2025, then dropped by 22.94% to $10.2 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $10.2 million, $13.3 million, and $10.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Edgewise Therapeutics 4.65 Bn 4.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.45 Mn
Mar 31, 2026 10.23 Mn
Dec 31, 2025 13.28 Mn
Sep 30, 2025 10.56 Mn
Jun 30, 2025 9.26 Mn
Mar 31, 2025 6.79 Mn
Dec 31, 2024 5.31 Mn
Sep 30, 2024 6.90 Mn
Jun 30, 2024 7.69 Mn
Mar 31, 2024 8.67 Mn
Dec 31, 2023 8.60 Mn
Sep 30, 2023 8.22 Mn
Jun 30, 2023 7.07 Mn
Mar 31, 2023 5.41 Mn
Dec 31, 2022 5.05 Mn
Sep 30, 2022 5.32 Mn
Jun 30, 2022 4.95 Mn
Mar 31, 2022 2.78 Mn
Dec 31, 2021 2.98 Mn
Sep 30, 2021 2.76 Mn